NEUROENDOCRINE CARCINOMA OF THE CERVIX

NEUROENDOCRINE CARCINOMA OF THE CERVIX was reported 15 times

NEUROENDOCRINE CARCINOMA OF THE CERVIX is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Ligand-1 Blocker [EPC] 2 0.0001
1 Topoisomerase Inhibitor [EPC] 6 0.0001
2 CTLA-4-directed Blocking Antibody [EPC] 3 0.0001
3 Human Immunoglobulin G [EPC] 1 0.0000
4 Programmed Death Receptor-1 Blocking Antibody [EPC] 4 0.0000
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 7 0.0000
6 Microtubule Inhibitor [EPC] 5 0.0000
7 Platinum-based Drug [EPC] 3 0.0000
8 Leukocyte Growth Factor [EPC] 1 0.0000
9 Kinase Inhibitor [EPC] 2 0.0000
10 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
11 Corticosteroid [EPC] 1 0.0000